Off-Label Drug Risks: Toward a New FDA Regulatory Approach

Authors

George Horvath, University of California Law San FranciscoFollow

Recommended Citation

George Horvath, Off-Label Drug Risks: Toward a New FDA Regulatory Approach, 29 ANNALS OF HEALTH L. & LIFE SCI. 101 (2020).

Publication Date

2020

Document Type

Article

Publication Title

Annals of Health Law & Life Society